[go: up one dir, main page]

MX2009007868A - Proceso para la preparacion de monoclorhidrato de 8-hidroxi-5-[(1r)-1-hidroxi-2[[(1r)-2-(4-metoxifenil)-1-metiletil ]amino]-etil]-2(1h)-quinolinona. - Google Patents

Proceso para la preparacion de monoclorhidrato de 8-hidroxi-5-[(1r)-1-hidroxi-2[[(1r)-2-(4-metoxifenil)-1-metiletil ]amino]-etil]-2(1h)-quinolinona.

Info

Publication number
MX2009007868A
MX2009007868A MX2009007868A MX2009007868A MX2009007868A MX 2009007868 A MX2009007868 A MX 2009007868A MX 2009007868 A MX2009007868 A MX 2009007868A MX 2009007868 A MX2009007868 A MX 2009007868A MX 2009007868 A MX2009007868 A MX 2009007868A
Authority
MX
Mexico
Prior art keywords
hydroxy
methylethyl
methoxyphenyl
ethyl
amino
Prior art date
Application number
MX2009007868A
Other languages
English (en)
Inventor
Maurizio Delcanale
Fausto Pivetti
Monica Bocchi
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of MX2009007868A publication Critical patent/MX2009007868A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

La invención se relaciona con un proceso para la preparación de monoclorhidrato de 8-hidroxi-5-[(1R)-1-hidroxi-2[[(1R)-2-(4-metoxi fenil)-1-metiletil]amino]etil]-2(1H)-quinolinona de la fórmula (I). También se describen los intermediarios útiles en el proceso.
MX2009007868A 2007-01-30 2008-01-22 Proceso para la preparacion de monoclorhidrato de 8-hidroxi-5-[(1r)-1-hidroxi-2[[(1r)-2-(4-metoxifenil)-1-metiletil ]amino]-etil]-2(1h)-quinolinona. MX2009007868A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07001950A EP1953143A1 (en) 2007-01-30 2007-01-30 Process for the preparation of 8-hydroxy-5-[(1R)-1-hydroxy-2[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone monohydrochloride
PCT/IB2008/000134 WO2008093188A1 (en) 2007-01-30 2008-01-22 Process for the preparation of 8-hydroxy-5-[(1r)-1-hydroxy-2[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]-ethyl]-2(1h)-quinolinone monohydrochloride

Publications (1)

Publication Number Publication Date
MX2009007868A true MX2009007868A (es) 2009-07-31

Family

ID=38055152

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009007868A MX2009007868A (es) 2007-01-30 2008-01-22 Proceso para la preparacion de monoclorhidrato de 8-hidroxi-5-[(1r)-1-hidroxi-2[[(1r)-2-(4-metoxifenil)-1-metiletil ]amino]-etil]-2(1h)-quinolinona.

Country Status (13)

Country Link
US (1) US8163922B2 (es)
EP (2) EP1953143A1 (es)
JP (1) JP2010516803A (es)
KR (1) KR101404263B1 (es)
CN (1) CN101611010B (es)
AU (1) AU2008211655B2 (es)
BR (1) BRPI0806411B8 (es)
CA (1) CA2676849C (es)
EA (1) EA018170B1 (es)
ES (1) ES2409740T3 (es)
MX (1) MX2009007868A (es)
WO (1) WO2008093188A1 (es)
ZA (1) ZA200905291B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR048339A1 (es) * 2004-03-24 2006-04-19 Chiesi Farma Spa Monoclorhidrato de 8- hidroxi-5-((1r)) -1- hidroxi-2- (((1r)-2 ( 4-metoxifenil) -1- metiletil) amino ) eti l) -2 (1h) - quinolinona en form acristalina y el proceso para su preparacion
EP2116537A1 (en) * 2008-05-07 2009-11-11 CHIESI FARMACEUTICI S.p.A. Polymorph of 8-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone monohydrochloride
EP2578570A1 (en) * 2011-10-07 2013-04-10 Almirall, S.A. Novel process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via novel intermediates of synthesis.
EP2641900A1 (en) 2012-03-20 2013-09-25 Almirall, S.A. Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor.
US9682935B2 (en) 2014-01-09 2017-06-20 Davuluri Ramamohan Rao Process for preparation of indacaterol or its pharmaceutically acceptable salts

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8334494D0 (en) * 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
EP1452179A1 (en) * 2003-02-27 2004-09-01 CHIESI FARMACEUTICI S.p.A. Novel medicament combination of a highly potent long-lasting beta2-agonist and a corticosteroid
AR048339A1 (es) 2004-03-24 2006-04-19 Chiesi Farma Spa Monoclorhidrato de 8- hidroxi-5-((1r)) -1- hidroxi-2- (((1r)-2 ( 4-metoxifenil) -1- metiletil) amino ) eti l) -2 (1h) - quinolinona en form acristalina y el proceso para su preparacion

Also Published As

Publication number Publication date
CN101611010B (zh) 2012-03-21
ES2409740T3 (es) 2013-06-27
JP2010516803A (ja) 2010-05-20
EP1953143A1 (en) 2008-08-06
WO2008093188A1 (en) 2008-08-07
KR101404263B1 (ko) 2014-06-05
CA2676849C (en) 2015-12-15
ZA200905291B (en) 2010-10-27
BRPI0806411B1 (pt) 2020-10-13
HK1135093A1 (en) 2010-05-28
CA2676849A1 (en) 2008-08-07
AU2008211655A1 (en) 2008-08-07
EP2109603A1 (en) 2009-10-21
US20090326231A1 (en) 2009-12-31
CN101611010A (zh) 2009-12-23
BRPI0806411A2 (pt) 2011-09-06
BRPI0806411B8 (pt) 2021-05-25
US8163922B2 (en) 2012-04-24
EA200900926A1 (ru) 2010-02-26
KR20090104820A (ko) 2009-10-06
AU2008211655B2 (en) 2013-04-04
EP2109603B1 (en) 2013-04-03
EA018170B1 (ru) 2013-06-28

Similar Documents

Publication Publication Date Title
MX2009007868A (es) Proceso para la preparacion de monoclorhidrato de 8-hidroxi-5-[(1r)-1-hidroxi-2[[(1r)-2-(4-metoxifenil)-1-metiletil ]amino]-etil]-2(1h)-quinolinona.
IL217962A0 (en) Process for the preparation of a 2-pyridylethylcarboxamide derivative
MA35452B1 (fr) 3-pyrimidin-4-yl-oxazolidin-2-ones comme inhibiteurs d'idh mutante
MY141224A (en) Crystalline form of a biphenyl compound
BRPI0407904A (pt) processo para a preparação de sal de 5-[(r)-2-(5,6-dietil-indan-2-ilaino) -1hidróxi-etil]-8-hidróxi-(1h)-quinolin-2-ona, útil como um agonista do adrenoceptor
WO2008062478A3 (en) Improved process for pure montelukast sodium through pure intermediates as well as novel amine salts
TN2012000177A1 (fr) Nouvelle association entre le 4-(3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide et un inhibiteur de l'acetylcholinesterase et les compositions pharmaceutiques qui la contiennent
PH12014502210A1 (en) Salts of 5-[(1r)-2-({2-[4-(2,2-difluoro-2-phenylethoxy)phenyl]ethyl}amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1h)-one
EP4223764A4 (en) AMIDE COMPOUND
EP4149510A4 (en) INTERMEDIATES AND SYNTHESIS FOR ENDOCHINE-LIKE QUINOLONE COMPOUNDS
AP2008004444A0 (en) New anti-malaria derivatives of 4-aminoquinoline
WO2008059521A3 (en) Novel process for the preparation of moxifloxacin hydrochloride and a novel polymorph of moxifloxacin
WO2010004578A3 (en) Novel and improved processes for the preparation of paliperidone
BR112015004901A2 (pt) compostos cristalinos
WO2009050734A3 (en) An industrially feasible process for the manufacture of bisquinoline derivatives by using substantially pure n-monosubstituted piperazines
EP4509179A3 (en) Polymorphs
WO2007057225A3 (en) Process for making montelukast and intermediates therefor
MD4345B1 (ro) Procedeu de sinteză şi forme cristaline ale hidroclorurii de 4-{3-¢cis-hexahidrociclopenta¢c]pirol-2(1H)-il]propoxi}benzamidă şi a bazei libere, compoziţii farmaceutice care le conţin pentru tratamentul tulburărilor cognitive şi psiho-comportamentale
WO2012168213A3 (en) Novel process for the synthesis of 7-chloro-4-(piperazin-1-yl)-quinoline
WO2008136693A3 (en) Process for the preparation of sodium salt of l-(((l(r)-(3-(2-(7-chloro-2- quinolinyl)-ethenyl)phenyl)-3-(2-(l-hydroxy-l- methylethyl)phenyl)propyl)sulfanyl)methyl)cyclopropaneacetic acid
TNSN06249A1 (en) 8-hydroxy-5-[(-hydroxy-2-[[ (1r)-2-(4-methoxyphenyl)-1-methylethyl] amino ][ethyl] -2(1h)-quinolinone monohydrochloride in crystalline form and the process for its preparation
AU2010277620A8 (en) Ring-annulated dihydropyrrolo[2,l-a]isoquinolines
WO2008146156A3 (en) An improved process for the preparation of aripiprazole
WO2021044230A8 (en) Process for the synthesis of the sodium salt of 4-[[(lr)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)-phenyl]methyl]-3,6-dihydro-4-methyl-2,6-dioxo-1(2h)-pyrimidinyl]-1- phenylethyl]amino]-butanoic acid (elagolix sodium salt) and intermediates of said process
IL181317A0 (en) Process for the preparation of 4,5-diamino shikimicacid

Legal Events

Date Code Title Description
FG Grant or registration